bezafibrate has been researched along with Kidney Failure, Chronic in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K | 1 |
| Fang, CC; Lee, YT; Su, TC; Yang, KC | 1 |
| Arai, D; Ichikawa, H; Kawamura, M; Kuriki, A; Sugie, M | 1 |
| Balcke, P; Haubenstock, A; Kopsa, H; Schmidt, P; Sertl, K; Zazgornik, J | 1 |
| Arnold, R; Barth, M; Blech, M; Kaiser, H; Koop, I; Rumpf, KW; Scheler, F | 1 |
| Grützmacher, P; Lang, W; Scheuermann, E | 1 |
| Heidland, A; Hörl, M; Hörl, WH | 1 |
| Anderson, P; Norbeck, HE | 2 |
| Bedani, PL; Gilli, P; Perini, L | 1 |
| Fusegawa, H; Kawashima, N; Sato, F; Shindo, R | 1 |
| Goya, T; Matsuo, K; Nakamoto, M; Nishihara, G; Takeda, K; Urabe, M; Yasunaga, C | 1 |
| Inoue, M; Jimi, T; Machida, H; Niwa, Y; Wakayama, Y | 1 |
| Nogués, X; Pedro-Botet, J; Pelegrí, A; Romero, R; Rubiés-Prat, J; Sentí, M | 1 |
| Chan, MK | 1 |
| Bommer, J; Feussner, G; Ziegler, R | 1 |
| Abshagen, U; Baldamus, CA; Grützmacher, P; Lang, PD; Radtke, HW; Scheuermann, EH; Schoeppe, W; Siede, W | 1 |
1 review(s) available for bezafibrate and Kidney Failure, Chronic
| Article | Year |
|---|---|
[A case report of acute neuromyopathy induced by concomitant use of colchicine and bezafibrate].
Topics: Acute Disease; Aged; Bezafibrate; Colchicine; Drug Synergism; Drug Therapy, Combination; Electromyography; Gout; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Male; Neural Conduction; Neuromuscular Diseases | 2005 |
1 trial(s) available for bezafibrate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
Topics: Adult; Bezafibrate; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Triglycerides | 1981 |
15 other study(ies) available for bezafibrate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan | 2009 |
Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
Topics: Bezafibrate; Combined Modality Therapy; Female; Glomerulonephritis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Plasma Exchange; Renal Dialysis; Rhabdomyolysis | 2005 |
[Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
Topics: Adult; Bezafibrate; Humans; Kidney; Kidney Failure, Chronic; Male; Rhabdomyolysis | 1984 |
[Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
Topics: Aged; Bezafibrate; Creatine Kinase; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myoglobin; Myoglobinuria; Rhabdomyolysis | 1984 |
[Fat and renal failure--therapeutic aspects].
Topics: Acute Kidney Injury; Animals; Bezafibrate; Carnitine; Charcoal; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Infusions, Parenteral; Kidney Failure, Chronic; Lipids; Physical Exertion; Rats; Renal Dialysis | 1982 |
Treatment of uremic hypertriglyceridaemia with bezafibrate.
Topics: Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipid Metabolism; Lipoproteins; Male; Triglycerides | 1982 |
Clinical pharmacokinetics of bezafibrate in patients with impaired renal function.
Topics: Adult; Aged; Bezafibrate; Clofibrate; Clofibric Acid; Creatinine; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Kinetics; Male; Middle Aged | 1981 |
Acute rhabdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis.
Topics: Acute Disease; Bezafibrate; Drug Overdose; Hemoglobins; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Rhabdomyolysis | 1994 |
[Case of secondary carnitine deficiency (in a patient undergoing hemodialysis), developing rhabdomyolysis due to dehydration and the action of a hypolipemic agent].
Topics: Adult; Bezafibrate; Carnitine; Dehydration; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Rhabdomyolysis | 1993 |
Blood monitoring of bezafibrate in a chronic hemodialysis patient.
Topics: Bezafibrate; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1997 |
[Bezafibrate myopathy in two patients with chronic renal failure].
Topics: Aged; Bezafibrate; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Molecular Weight; Rhabdomyolysis | 1992 |
Effect of bezafibrate on lipoprotein (a) and triglyceride-rich lipoproteins, including intermediate-density lipoproteins, in patients with chronic renal failure receiving haemodialysis.
Topics: Adult; Aged; Bezafibrate; Humans; Kidney Failure, Chronic; Lipoproteins; Lipoproteins, IDL; Middle Aged; Renal Dialysis; Triglycerides | 1992 |
Sustained-release bezafibrate corrects lipid abnormalities in patients on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Aged; Bezafibrate; Cholesterol, HDL; Coronary Disease; Delayed-Action Preparations; Diabetes Complications; Drug Evaluation; Female; Humans; Hypertriglyceridemia; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Muscular Diseases; Peritoneal Dialysis, Continuous Ambulatory | 1990 |
Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
Topics: Apolipoproteins E; Arteriosclerosis; Bezafibrate; Cholesterol; Female; Genetic Carrier Screening; Humans; Hyperlipoproteinemia Type III; Kidney Failure, Chronic; Kidney Function Tests; Lipids; Lipoproteins; Middle Aged; Renal Dialysis; Risk Factors; Triglycerides | 1990 |
Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects.
Topics: Administration, Oral; Adult; Aged; Bezafibrate; Cholesterol; Coronary Disease; Female; Half-Life; Humans; Hyperlipoproteinemia Type IV; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Triglycerides | 1986 |